Jones David Scott
Related Filers (1)
Other (3)
144
Friday, 2/2/2024
Filing for proposed sale of securities under Rule 144
144
Wednesday, 1/24/2024
Filing for proposed sale of securities under Rule 144
144
Monday, 1/22/2024
Filing for proposed sale of securities under Rule 144
Ownership (18)
4
Tuesday, 2/13/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/5/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/29/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/26/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/24/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/9/2024
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/22/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/13/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/10/2023
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/2/2022
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/11/2022
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/3/2021
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/23/2021
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/2/2021
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/2/2020
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/3/2020
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/12/2019
EyePoint Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/12/2019
EyePoint Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities